VanEck Pharmaceutical ETF (PPH) is an ETF managed by Independent / Boutique. Its largest position is ELI LILLY & Co (LLY), representing 18.70% of fund assets.
VanEck Pharmaceutical ETF Portfolio Holdings
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- PPH
- Type:
- ETF
- Manager:
- Independent / Boutique
- Total Assets:
- —
- Report Date:
- Mar 31, 2026
- Filing Date:
- May 28, 2026
| Holding | Weight | Market Value | Shares |
|---|---|---|---|
|
-
ELI LILLY & Co
|
18.70% | $240,475,706.04 | 261,452 |
|
-
NOVARTIS AG
|
10.76% | $138,391,041.75 | 905,997 |
|
-
Merck & Co., Inc.
|
9.68% | $124,480,181.86 | 1,034,834 |
|
-
PFIZER INC
|
5.23% | $67,220,262.72 | 2,393,884 |
|
-
NOVO NORDISK A S
|
4.81% | $61,852,271.25 | 1,683,055 |
|
-
Sanofi
|
4.73% | $60,803,786.34 | 1,262,013 |
|
-
BRISTOL MYERS SQUIBB CO
|
4.62% | $59,474,784.95 | 980,623 |
|
-
GSK plc
|
4.58% | $58,860,355.76 | 1,066,504 |
|
-
ASTRAZENECA PLC
|
4.40% | $56,574,331.98 | 286,859 |
|
-
JOHNSON & JOHNSON
|
4.34% | $55,783,407.96 | 228,209 |
|
-
MCKESSON CORP
|
4.24% | $54,476,142.72 | 62,952 |
|
-
AbbVie Inc.
|
4.12% | $52,971,211.93 | 243,557 |
|
-
Cencora, Inc.
|
3.74% | $48,049,911.98 | 152,957 |
|
-
Zoetis Inc.
|
3.47% | $44,684,798.52 | 378,012 |
|
-
Haleon plc
|
3.22% | $41,387,536.19 | 4,134,619 |
|
-
TAKEDA PHARMACEUTICAL CO LTD
|
3.15% | $40,474,515.48 | 2,185,449 |
|
-
TEVA PHARMACEUTICAL INDUSTRIES LTD
|
2.83% | $36,392,971.92 | 1,208,266 |
|
-
STATE STREET GLOBAL ADVISORS
|
1.89% | $24,267,401.50 | 24,267,402 |
|
-
Viatris Inc
|
0.90% | $11,551,428.28 | 855,028 |
|
-
Jazz Pharmaceuticals plc
|
0.80% | $10,294,717.75 | 54,455 |
|
-
Axsome Therapeutics, Inc.
|
0.51% | $6,609,189.06 | 39,103 |
|
-
Elanco Animal Health Inc
|
0.35% | $4,547,346.11 | 190,027 |
|
-
CORCEPT THERAPEUTICS INC
|
0.22% | $2,856,366.60 | 70,860 |
|
-
Bausch Health Companies Inc.
|
0.10% | $1,334,221.20 | 247,078 |
|
-
Organon & Co.
|
0.10% | $1,260,116.30 | 210,370 |
|
-
PERRIGO Co plc
|
0.07% | $904,082.46 | 84,179 |
Advertisement (320x50)